Cultivated Dairy
Vivici achieves GRAS status for its nature-equivalent whey protein

Phoebe Fraser
19 February 2024
Vivici achieves GRAS status for its nature-equivalent whey protein

The Netherlands-based alt-dairy start-up, Vivici, has announced it has achieved self-affirmed Generally Recognized as Safe (GRAS) status for its beta-lactoglobulin protein in the US.
Vivici's beta-lactoglobulin is a highly pure dairy whey protein equivalent to nature's version. The protein is said to contain all essential amino acids required by the human body, have a high amount of leucine and branched-chain amino acids (BCAA) and be rapidly absorbed in the blood plasma.
The ingredient is also free from lactose, cholesterol, hormones and antibiotics. The protein has a neutral colour and flavour and, according to Vivici, is ready for use across a wide range of products, including ready-to-mix protein powders, protein bars and RTD protein beverages.
Vivici's CTO, Marcel Wubbolts, said: “Nutritionally, Vivici's beta-lactoglobulin isolate is superior to plant protein isolates, even outperforming whey protein isolates in specific applications because it's higher in the amino acids beneficial for muscle growth and recovery”.
Vivici's CEO Stephan van Sint Fiet added: “We want to work closely with all innovative food and beverage players in the market who believe their brand could benefit from a more sustainably produced ethically sourced, yet highly functional protein ingredient. The focus of our food science team is to support our brand customers to bring outstanding products to market."
#Vivici #theNetherlands
Related news
Vivici secures 'No Questions' FDA letter for precision-fermented whey protein
Dutch start-up Vivici secures a ‘No Questions’ letter from the FDA for its precision-fermented whey protein, Vivitein BLG, a key milestone.
Vivici brings animal-free protein ingredient to US market
Vivici has launched Vivitein BLG in the US, offering a new protein ingredient for food and beverage companies.
Vivici secures €32.5m in Series A funding for precision fermentation expansion
Vivici has raised €32.5 million in Series A funding to expand its precision fermentation dairy protein business.
Cultivated Dairy
Vivici achieves GRAS status for its nature-equivalent whey protein

Phoebe Fraser
19 February 2024